Stockscreener 앱 받기
2.11
0.94%
-0.02
시장 영업 전:
2.09
-0.02
-0.95%
전일 마감가:
$2.13
열려 있는:
$2.17
하루 거래량:
188.41K
Relative Volume:
0.16
시가총액:
$6.48M
수익:
$2.45M
순이익/손실:
$-5.47M
주가수익비율:
-0.0357
EPS:
-59.1634
순현금흐름:
$-6.05M
1주 성능:
-8.66%
1개월 성능:
-17.58%
6개월 성능:
-97.89%
1년 성능:
-98.97%
1일 변동 폭
$2.0436
$2.17
1주일 범위
$2.0436
$2.2399
52주 변동 폭
$1.7402
$218.00
Pmgc Holdings Inc Stock (ELAB) Company Profile
명칭
Pmgc Holdings Inc
전화
18667944940
주소
120 NEWPORT CENTER DRIVE, NEWPORT BEACH
ELAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAB
Pmgc Holdings Inc
|
2.11 | 6.48M | 2.45M | -5.47M | -6.05M | -59.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Pmgc Holdings Inc 주식(ELAB)의 최신 뉴스
PMGC Holdings (NASDAQ:ELAB) Stock Quotes, Forecast and News Summary - Benzinga
South Side biotech firm Carmell Therapeutics acquires skincare company - The Business Journals
PMGC Holdings meets Nasdaq compliance; subsidiaries rebrand - MSN
PMGC Holdings meets Nasdaq compliance; subsidiaries rebrand By Investing.com - Investing.com South Africa
PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture - The Manila Times
Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail
Carmell Announces Closing of Elevai Skincare Acquisition - The Manila Times
Carmell Acquires Elevai Skincare in $1.1M Stock Deal, Expanding Beauty Portfolio - StockTitan
PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries - GlobeNewswire
Alphabet Cl A (GOOGL-Q) QuotePress Release - The Globe and Mail
Carmell's earning potential swells with Elevai acquisition - MSN
Carmell acquires Elevai Skincare - Fashion Network
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy - The Manila Times
PMGC Holdings Inc. Following Skincare Subsidiary Sale, Embarks on Bold Growth Strategy - GlobeNewswire Inc.
Carmell To Acquire Elevai Skincare - citybiz
Why Biotechnology Company Carmell Shares Are Rocketing On Thursday - Benzinga
Carmell's earning potential swells with Elevai acquisition (CTCX) - Seeking Alpha
Cardill More than Doubles on Acquisition - Baystreet.ca
Carmell Corporation acquires Elevai assets for $1.1M By Investing.com - Investing.com Australia
Carmell Corporation acquires Elevai assets for $1.1M - Investing.com
Carmell Announces Execution of Definitive Agreement to - GlobeNewswire
Carmell Acquires Elevai Skincare's $2.5M Revenue Portfolio, Expanding Bio-Aesthetic Platform - StockTitan
Elevai Labs (NASDAQ:ELAB) Announces Resignation of Director - Defense World
PMGC Holdings director resigns, effective immediately By Investing.com - Investing.com Australia
PMGC Holdings director resigns, effective immediately - Investing.com India
Elevai Labs Completes Reincorporation to Nevada, Now PMGC Holdings Inc.On December 20, 2024, Elevai Labs Inc. finalized its reincorporation process to become PMGC Holdings Inc., as disclosed in an 8-K filing with the Securities and Exchange Commis - Defense World
PMGC Holdings Inc. completes reincorporation in Nevada - Investing.com India
PMGC Holdings Inc. completes reincorporation in Nevada By Investing.com - Investing.com Australia
Elevai Labs, Inc. signed a license agreement to acquire a Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology from INmune Bio, Inc.. - Marketscreener.com
Elevai Labs (NASDAQ: ELAB) Dismisses TPS Thayer, LLC as Independent Registered Public Accounting Firm - Defense World
Elevai Labs Inc. Announces Resignation of Hatem Abou-Sayed MD as Member of the Board of Directors and as Chief Medical Officer - Marketscreener.com
Elevai Labs Inc. Announces Executive Changes - Marketscreener.com
Elevai Biosciences Announces FDA Regulatory Pathway for EL-22 - Marketscreener.com
Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada - Yahoo Finance
Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada - GlobeNewswire
Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada - The Manila Times
Fixing of coupon rate effective from 1 January 2025 - The Manila Times
Elevai Labs Announces Major Rebrand to PMGC Holdings, Expands into Multi-Portfolio Growth Company - StockTitan
Elevai Labs announces withdrawal of offer to exchange - MSN
Elevai Biosciences gears up for FDA talks on obesity drug By Investing.com - Investing.com Canada
Elevai Biosciences gears up for FDA talks on obesity drug - Investing.com India
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation - The Manila Times
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., - GlobeNewswire
Elevai's Novel Obesity Drug EL-22 Advances Toward FDA Review, Targets Muscle Preservation Breakthrough - StockTitan
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market - The Manila Times
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches - GlobeNewswire
Elevai Labs Disrupts Hair Care Market with AI-Powered Root Renewal System Launch | ELAB Stock News - StockTitan
Data-Based Insights About Elevai Labs Inc (ELAB) - Stocks Register
ELABElevai Labs, Inc. Latest Stock News & Market Updates - StockTitan
Elevai Labs Inc. Announces Record-Breaking Sales Month in 2024 for Elevai Skincare Division - The Manila Times
Pmgc Holdings Inc (ELAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):